EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epidemiology and economic burden of Wilson disease in France: A nationwide population‐based study

Shona Fang, Martina Furegato, Jessica Azzi, Eduardo Couchonnal-Bedoya, Dominique Debray

Journal of Inherited Metabolic Disease · 2025-01 · 48 (1)

DOI: 10.1002/jimd.12822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 24.11.2024. Verfasst von Shona Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Real World Science, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Hepatolenticular Degeneration, Cost of Illness. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Alexion Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wilson disease (WD) is a rare inherited copper metabolism disorder characterized by progressive pathological deposition of copper, primarily in the liver and brain. This longitudinal retrospective study conducted using the French national claims (Système National des Données de Santé [SNDS]) database assessed WD prevalence in France, described patients' characterizations and healthcare resource use and associated costs. Patients with WD were identified from SNDS using the International Classification of Diseases, 10th Revision code E83.0 for copper metabolism disorder or a long‐term disease (affection de longue durée [ALD]) associated with this code between 2010 and 2019. Patients were categorized into hepatic, neurological, and psychiatric sub‐cohorts. We identified 2287 patients with WD yielding a crude prevalence of 1 case per 33 898 individuals in 2019. The mean age at inclusion was 39.9 (standard deviation [SD] 22.8) years, 11 years more than that of the incident cohort (28.6, SD 20.3) identified via ALD, and 1180 (51.6%) patients were male. The crude mortality was 3.2% (in total 370 patients died). Overall, 1011 (44.2%), 754 (33.0%), and 414 (18.1%) patients experienced hepatic, neurological, and psychiatric manifestations, respectively. In total, 922 (40.3%) patients were reimbursed for WD‐specific treatment, the most common being D‐penicillamine (74.8%), and 201 (8.8%) underwent liver transplantation. The average annual hospitalization cost per patient was 4273.7€ (SD 11916.0). At least one sick leave was reported for 533 (23.3%) patients, with an annual average cost of 788.7€ (SD 1328.6). Our findings provide an updated understanding of the prevalence of WD, and indicate a considerable level of morbidity in this population, as well as a high level of direct/indirect costs associated with WD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatolenticular DegenerationCost of IllnessHumansFranceMaleFemaleAdultRetrospective StudiesMiddle AgedLongitudinal StudiesYoung AdultAdolescentPrevalenceChildHealth Care CostsChild, PreschoolLiver TransplantationAgedHospitalization

Stichwörter der Autor:innen

D‐penicillamineFranceSNDSWilson diseasehealthcare resource utilizationreal‐world evidence

Autor:innen und Institutionen

  • Epidemiology and Real World Science, Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA.
  • Oracle Life Sciences, Paris, France.
  • Hospital for Women Mother and Child, University Hospital Center of Lyon, Lyon, France.
  • National Reference Center for Wilson Disease and Other Rare Copper Related Diseases, Hôpital Fondation Adolphe de Rothschild, Paris, France.

Förderung

  • Alexion Pharmaceuticals

Zitieren

APA

Fang, S., Furegato, M., Azzi, J., Couchonnal-Bedoya, E., & Debray, D. (2025). Epidemiology and economic burden of Wilson disease in France: A nationwide population‐based study. Journal of Inherited Metabolic Disease, 48(1). https://doi.org/10.1002/jimd.12822

Vancouver

Fang S, Furegato M, Azzi J, Couchonnal-Bedoya E, Debray D. Epidemiology and economic burden of Wilson disease in France: A nationwide population‐based study. Journal of Inherited Metabolic Disease. 2025;48(1). doi:10.1002/jimd.12822

BibTeX
@article{Fang2025,
  author = {Fang, Shona and Furegato, Martina and Azzi, Jessica and Couchonnal-Bedoya, Eduardo and Debray, Dominique},
  title = {Epidemiology and economic burden of Wilson disease in France: A nationwide population‐based study},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  volume = {48},
  number = {1},
  doi = {10.1002/jimd.12822}
}
Kostenlos starten →